These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

323 related articles for article (PubMed ID: 37480450)

  • 21. Roles and mechanisms of copper homeostasis and cuproptosis in osteoarticular diseases.
    Han J; Luo J; Wang C; Kapilevich L; Zhang XA
    Biomed Pharmacother; 2024 May; 174():116570. PubMed ID: 38599063
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Copper metabolism and cuproptosis in human malignancies: Unraveling the complex interplay for therapeutic insights.
    Abdullah KM; Kaushal JB; Takkar S; Sharma G; Alsafwani ZW; Pothuraju R; Batra SK; Siddiqui JA
    Heliyon; 2024 Mar; 10(5):e27496. PubMed ID: 38486750
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prediction of risk and clinical outcome of cuproptosis in lung squamous carcinoma.
    Zhang Y; Zhou J; Li H; Liu Y; Li J
    BMC Pulm Med; 2023 Jun; 23(1):205. PubMed ID: 37308925
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Role of cuproptosis in understanding diseases.
    Cao S; Wang Q; Sun Z; Zhang Y; Liu Q; Huang Q; Ding G; Jia Z
    Hum Cell; 2023 Jul; 36(4):1244-1252. PubMed ID: 37154876
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Identification and validation of a novel cuproptosis-related signature as a prognostic model for lung adenocarcinoma.
    Chen Y; Tang L; Huang W; Zhang Y; Abisola FH; Li L
    Front Endocrinol (Lausanne); 2022; 13():963220. PubMed ID: 36353226
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Copper homeostasis and cuproptosis in tumor pathogenesis and therapeutic strategies.
    Bian C; Zheng Z; Su J; Chang S; Yu H; Bao J; Xin Y; Jiang X
    Front Pharmacol; 2023; 14():1271613. PubMed ID: 37767404
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Focus on cuproptosis: Exploring new mechanisms and therapeutic application prospects of cuproptosis regulation.
    Hao D; Luo W; Yan Y; Zhou J
    Biomed Pharmacother; 2024 Sep; 178():117182. PubMed ID: 39053428
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Protein lipoylation: mitochondria, cuproptosis, and beyond.
    Lin CH; Chin Y; Zhou M; Sobol RW; Hung MC; Tan M
    Trends Biochem Sci; 2024 Aug; 49(8):729-744. PubMed ID: 38714376
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Ferroptosis and cuproptosis: Metal-dependent cell death pathways activated in response to classical chemotherapy - Significance for cancer treatment?
    Kciuk M; Gielecińska A; Kałuzińska-Kołat Ż; Yahya EB; Kontek R
    Biochim Biophys Acta Rev Cancer; 2024 Jul; 1879(4):189124. PubMed ID: 38801962
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mechanisms of cuproptosis and its relevance to distinct diseases.
    Lou QM; Lai FF; Li JW; Mao KJ; Wan HT; He Y
    Apoptosis; 2024 Aug; 29(7-8):981-1006. PubMed ID: 38824478
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cuproptosis as the new kryptonite of cancer: a copper-dependent novel cell death mechanism with promising implications for the treatment of hepatocellular carcinoma.
    Ozkan E; Bakar-Ates F
    J Cancer Res Clin Oncol; 2023 Dec; 149(19):17663-17670. PubMed ID: 37843555
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cuproptosis predicts the risk and clinical outcomes of lung adenocarcinoma.
    Hu Q; Wang R; Ma H; Zhang Z; Xue Q
    Front Oncol; 2022; 12():922332. PubMed ID: 36003780
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Radiosensitization-Related Cuproptosis LncRNA Signature in Non-Small Cell Lung Cancer.
    Xu Q; Liu T; Wang J
    Genes (Basel); 2022 Nov; 13(11):. PubMed ID: 36360316
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cuproptosis: Mechanism, role, and advances in urological malignancies.
    Wu J; He J; Liu Z; Zhu X; Li Z; Chen A; Lu J
    Med Res Rev; 2024 Jul; 44(4):1662-1682. PubMed ID: 38299968
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cuproptosis and its application in different cancers: an overview.
    Xu L; Liu K; Wang F; Su Y
    Mol Cell Biochem; 2023 Dec; 478(12):2683-2693. PubMed ID: 36914880
    [TBL] [Abstract][Full Text] [Related]  

  • 36. ATF3/SPI1/SLC31A1 Signaling Promotes Cuproptosis Induced by Advanced Glycosylation End Products in Diabetic Myocardial Injury.
    Huo S; Wang Q; Shi W; Peng L; Jiang Y; Zhu M; Guo J; Peng D; Wang M; Men L; Huang B; Lv J; Lin L
    Int J Mol Sci; 2023 Jan; 24(2):. PubMed ID: 36675183
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Copper Metabolism and Cuproptosis: Molecular Mechanisms and Therapeutic Perspectives in Neurodegenerative Diseases.
    Ban XX; Wan H; Wan XX; Tan YT; Hu XM; Ban HX; Chen XY; Huang K; Zhang Q; Xiong K
    Curr Med Sci; 2024 Feb; 44(1):28-50. PubMed ID: 38336987
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Elesclomol, a copper-transporting therapeutic agent targeting mitochondria: from discovery to its novel applications.
    Tarin M; Babaie M; Eshghi H; Matin MM; Saljooghi AS
    J Transl Med; 2023 Oct; 21(1):745. PubMed ID: 37864163
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Exploring cuproptosis as a mechanism and potential intervention target in cardiovascular diseases.
    Yang Y; Feng Q; Luan Y; Liu H; Jiao Y; Hao H; Yu B; Luan Y; Ren K
    Front Pharmacol; 2023; 14():1229297. PubMed ID: 37637426
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Emerging insights into cuproptosis and copper metabolism: implications for age-related diseases and potential therapeutic strategies.
    Fan H; Wang K; Zhao X; Song B; Yao T; Liu T; Gao G; Lu W; Liu C
    Front Aging Neurosci; 2024; 16():1335122. PubMed ID: 38715962
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.